GREAT FALLS, Mont. -- Buttrey Food & Drug here said last week it has received an acquisition proposal of $10 per share in cash for its 8.6 million outstanding shares of common stock. The acquisition price would be $86 million, plus assumption of $43.9 million of debt. Buttrey officials declined to name the company that made the proposal or discuss details of the proposed deal. However, one observer told SN, "The proposed buyer has got to be an industry player who can bring synergies to ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.